A federal judge indicates the Court will soon begin allowing veterans who filed lawsuits over hearing damage to register to participate in a recent 3M Combat Arms earplug settlement agreement.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The FTC has agreed to allow Amgen to buy Horizon, the manufacturer of Tepezza, after proposing a consent decree which seeks to prevent the company from gaining an overwhelming advantage…
Plaintiffs and defendants in Tepezza litigation have filed dueling bellwether selection protocols which would lead to the first early test cases over claims the thyroid eye disease drug causes hearing…
3M is reportedly proposing a $5.5 billion settlement to resolve Combat Arms hearing loss lawsuits filed by hundreds of thousands of U.S. military personnel.
A Tepezza hearing loss lawsuit claims a man suffered permanent hearing damage after receiving infusions of the thyroid eye disease drug.
3M has reported financial losses tied to the expense of massive litigation filed against it in both firefighter foam lawsuits and hearing loss lawsuits linked to its Combat Arms military…
Parties will meet on July 31 to discuss the next steps in moving Tepezza hearing loss litigation forward.
The FDA has added new Tepezza hearing loss label warnings, alerting patients and healthcare professionals to the risk of permanent hearing damage linked to the thyroid eye disease drug.
Nearly 17% of users report suffering hearing problems from Tepezza over the first six months of use, according to the findings of a new study.
